These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30347490)

  • 1. Plasma concentrations of etonogestrel in women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
    Ginstman C; Frisk J; Carlsson B; Ärlemalm A; Hägg S; Brynhildsen J
    BJOG; 2019 Mar; 126(4):486-492. PubMed ID: 30347490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.
    Ginstman C; Kopp Kallner H; Fagerberg-Silwer J; Carlsson B; Ärlemalm A; Böttiger Y; Brynhildsen J
    Obes Surg; 2020 Jun; 30(6):2217-2224. PubMed ID: 32030619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Plasma concentrations of etonogestrel in obese women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
    Rottenstreich A; Elazary R; Elchalal U; Levin G
    BJOG; 2019 Apr; 126(5):676-677. PubMed ID: 30461162
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery.
    Moreira de Brito C; de Melo ME; Mancini MC; Santo MA; Cercato C
    Surg Obes Relat Dis; 2021 Apr; 17(4):673-681. PubMed ID: 33547015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Authors' reply re: Plasma concentrations of etonogestrel in obese women using oral desogestrel before and after Roux-en-Y gastric bypass surgery: a pharmacokinetic study.
    Ginstman C; Brynhildsen J;
    BJOG; 2019 Apr; 126(5):677. PubMed ID: 30461174
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of the etonogestrel contraceptive implant in obese women.
    Mornar S; Chan LN; Mistretta S; Neustadt A; Martins S; Gilliam M
    Am J Obstet Gynecol; 2012 Aug; 207(2):110.e1-6. PubMed ID: 22717269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.
    Tandra S; Chalasani N; Jones DR; Mattar S; Hall SD; Vuppalanchi R
    Ann Surg; 2013 Aug; 258(2):262-9. PubMed ID: 23222033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery.
    Krieger CA; Cunningham JL; Reid JM; Langman LJ; Grothe KB; Clark MM; Dierkhising RA
    Pharmacotherapy; 2017 Nov; 37(11):1374-1382. PubMed ID: 28845898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports.
    Ciangura C; Corigliano N; Basdevant A; Mouly S; Declèves X; Touraine P; Lloret-Linares C
    Contraception; 2011 Dec; 84(6):649-51. PubMed ID: 22078197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting iron absorption from an effervescent iron supplement in obese patients before and after Roux-en-Y gastric bypass: a preliminary study.
    Gesquiere I; Steenackers N; Lannoo M; Foulon V; Mertens A; Gils A; de Hoon J; Augustijns P; Matthys C; Van der Schueren B
    J Trace Elem Med Biol; 2019 Mar; 52():68-73. PubMed ID: 30732902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug disposition before and after gastric bypass: fenofibrate and posaconazole.
    Gesquiere I; Hens B; Van der Schueren B; Mols R; de Hoon J; Lannoo M; Matthys C; Foulon V; Augustijns P
    Br J Clin Pharmacol; 2016 Nov; 82(5):1325-1332. PubMed ID: 27367040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Archer DF; Timmer CJ; Lammers P
    Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery.
    Kröll D; Stirnimann G; Vogt A; Lai DLL; Borbély YM; Altmeier J; Schädelin S; Candinas D; Alberio L; Nett PC
    Br J Clin Pharmacol; 2017 Jul; 83(7):1466-1475. PubMed ID: 28121368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
    Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine and metabolites plasma levels after administration of sustained release morphine in Roux-en-Y gastric bypass subjects versus matched control subjects.
    Hachon L; Reis R; Labat L; Poitou C; Jacob A; Declèves X; Lloret-Linares C
    Surg Obes Relat Dis; 2017 Nov; 13(11):1869-1874. PubMed ID: 28864105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.
    Chan LN; Lin YS; Tay-Sontheimer JC; Trawick D; Oelschlager BK; Flum DR; Patton KK; Shen DD; Horn JR
    Pharmacotherapy; 2015 Apr; 35(4):361-9. PubMed ID: 25757445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery.
    Yska JP; Wanders JTM; Odigie B; Apers JA; Emous M; Totté ERE; Boerma EC; Ubels FL; Woerdenbag HJ; Frijlink HW; Wilffert B; van Roon EN
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e19-e24. PubMed ID: 32296500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics.
    Portolés-Pérez A; Paterna ABR; Sánchez Pernaute A; Torres García AJ; Moreno Lopera C; Chicharro LM; Bandrés F; López-Picado A; Rubio MA; Castrillón EV
    Obes Facts; 2022; 15(2):271-280. PubMed ID: 34979510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and serum protein binding of 3-keto-desogestrel in women during three cycles of treatment with a low-dose combination oral contraceptive.
    Kuhnz W; al-Yacoub G; Power J; Ormesher SE; Back DJ; Jütting G
    Arzneimittelforschung; 1992 Sep; 42(9):1142-6. PubMed ID: 1445483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.
    Mitrov-Winkelmolen L; van Buul-Gast MW; Swank DJ; Overdiek HWPM; van Schaik RHN; Touw DJ
    Obes Surg; 2016 Sep; 26(9):2051-2058. PubMed ID: 26797705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.